Compound Detail
CHEMBL3581921
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
CCCCCCC[C@@H]1C[C@@H]2CC[C@H]3[C@@H](C(=O)O[C@H](C)CCCCCCC[C@@H]4C[C@@H]5CC[C@@H]6C[C@H](C)N=C(N4)N65)[C@@H](C)N=C(N1)N23
Basic Information
| ChEMBL ID | CHEMBL3581921 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | RKQUPIHFCPEGLX-OOXHEEBBSA-N |
3
Targets
3
Activities
1
Assay Types
0
PK Parameters
3
Publications
0
Known Names
Molecular Properties
625.0
MW (Da)
6.92
ALogP
8
HBA
2
HBD
81.6
PSA (Ų)
0.14
QED
2
Ro5 Violations
16
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 5.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Leishmania infantum CHEMBL612848 | IC50 | 5.4 | 5.4 | 4000.0 | 1 |
| Trypanosoma cruzi CHEMBL368 | IC50 | 5.3 | 5.3 | 5000.0 | 1 |
| LLC-MK2 CHEMBL614691 | IC50 | 5.0 | 5.0 | 10000.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Leishmania infantum | IC50 | = | 4000.0 | nM | 5.4 | Antileishmanial activity against promastigote stage of Leishmania infantum MHOM/... | 25924111 |
| Trypanosoma cruzi | IC50 | = | 5000.0 | nM | 5.3 | Antitrypanosomal activity against trypomastigote stage of Trypanosoma cruzi Y as... | 25924111 |
| LLC-MK2 | IC50 | = | 10000.0 | nM | 5.0 | Cytotoxicity against rhesus monkey LLC-MK2 cells assessed as inhibition of cell ... | 25924111 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 25924111 | 10.1021/acs.jnatprod.5b00070 | Leishmania infantum | 2 |
| 25924111 | 10.1021/acs.jnatprod.5b00070 | Trypanosoma cruzi | 2 |
| 25924111 | 10.1021/acs.jnatprod.5b00070 | LLC-MK2 | 1 |
Data from ChEMBL 36 via Core Engine